Abstract
The effect of the new substituted benzimidazole proton pump inhibitor, lansoprazole, on pharmacokinetics and metabolism of theophylline has been studied in healthy adults given oral lansoprazole 30 mg once daily for 11 days. On Days 4 and 11 of 300 mg aminophylline was simultaneously administered orally and blood samples for theophylline analysis were taken over 24 h. Urine samples were collected for up to 24 h and were assayed for theophylline and its major metabolites 1,3-dimethyluric acid (1,3-DMU), 1-methyluric acid (1-MU) and 3-methylxanthine (3-MX). The pharmacokinetic parameters of theophylline were determined, and the urinary recovery of unchanged theophylline and its major metabolites were calculated.
After administration of lansoprazole for 4 days, no significant alteration in the terminal elimination half-life (t 1/2β) or the mean residence time (MRT) was detected. However, there was a significant decrease of about 13% in the area under the plasma concentration-time curve (AUC) and a significant increase of about 19% in the apparent clearance (CLapp). Lansoprazole treatment for 11 days caused a significant decrease of approximately 12% in t 1/2β and about 10% in the MRT of theophylline, although neither AUC nor CLapp showed a significant alteration. The excretion of 3-MX in the urine was significantly increased by about 20% after lansoprazole treatment for 4 and 11 days, although there was no significant alteration in the excretion of unchanged theophylline, 1,3-DMU or 1-MU.
The results indicate that repeated administration of lansoprazole to humans induces the hepatic microsomal P-450-dependent drug oxidation system that mediates N-1-demethylation of theophylline, consequently increasing its metabolism.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Wilkinson C F, Hetnarski K, Yellen T O (1972) Imidazole derivatives — A new class of microsomal enzyme inhibitors. Biochem Pharmacol 21:3187–3192
Wilkinson CF, Hetnarski K, Hicks L J (1974) Substituted imidazoles as inhibitors of microsomal oxidation and insecticide synergists. Pest Biochem Physiol 4:299–312
Hamphries T J (1991) Clinical implications of drug interactions with the cytochrome P-450 enzyme system associate with omeprazole. Dig Dis Sci 36:1665–1669
Simon W A, Budingen C, Fahr S, Kinder B, Koske M (1991) The H+,K+ATPase inhibitor pantoprazole (BY1023/SK & F96022) interacts less with cytochrome P-450 than omeprazole and lansoprazole. Biochem Pharmacol 42:347–355
Jonkman J H G, Upton R A (1984) Pharmacokinetic drug interactions with theophylline. Clin Pharmacokinet 9:309–334
Jonkman J H G, Nicholson K G, Farrow P R, Eckert M, Grasmeijer G, Oosterhuis B, Denoord OE, Guentert T W (1989) Effect of α-interferon on theophylline pharmacokinetics and metabolism. Br J Clin Pharmacol 27:795–802
Jenne J W (1982) Theophylline: a remarkable window to the hepatic microsomal oxidases. Chest 81:529–530
Muir K T, Jonkman J H G, Tang D, Kunitani M, Riegelman S (1980) Simultaneous determination of theophylline and its major metabolites in urine by reversed-phase ion-pairhigh-performance liquid chromatography. J Chromatogr 221:85–95
Kobayashi T, Mitani M, Miwa K, Yoshida K, Naeshiro I, Ikeda M, Kimura T, Shimomura H, Tateyama S (1990) Metabolism of AG-1749, a new proton pump inhibitor, in rats, and dogs (in Japanese). Yakuri-to-Tiryou Basic Pharmacol Ther 18:3437–3447
Tuker G T (1994) The interaction of proton pump inhibitors with cytochromes P450. Aliment Pharmacol Ther 8:33–38
Miwa K, Mitani M, Tsukamoto T, Yoshida K, Kobayashi T, Kimura T, Shimomura H, Tateyama S (1990) Metabolic fate of AG-1749, a new proton pump inhibitor, in rats, mice, and dogs (in Japanese). Yakuri-to-Tiryou Basic Pharmacol Ther 18:3413–3435
Granneman G, Winters E, Locke C, Leese P, Karol M, Cavanaugh J (1991) Lack of effect of concomitant lansoprazole on steady-state theophylline pharmacokinetics. Gastroenterol 33:133
Cornish HH, Christman AA (1957) A study of the metabolism of theobromine, theobromine, theophylline, and caffeine in man. J Biol Chem 223:315–323
Jonkman JHG, Tang D, Upton RA, Riegelman S (1981) Measurement of excretion chracteristics of theophylline and its major metabolites. Eur J Clin Pharmacol 20:435–441
Nousbaum JB, Berthou F, Carlhant D, Riche C, Robaszkiewicz M, Gouerou H (1994) Four-week treatment with omeprazole increases the metabolism caffeine. Am J Gastroenterol 89:371–375
Guglar R and Jensen JC (1987) Drugs other than H2-receptor antagonists as clinically important inhibitors of drug metabolism in vivo. Pharmacol Ther 33:133–137
Andersson T (1991) Omeprazole drug interaction studies. Clin Pharmacokinet 21:195–212
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kokufu, T., Ihara, N., Sugioka, N. et al. Effects of lansoprazole on pharmacokinetics and metabolism of theophylline. Eur J Clin Pharmacol 48, 391–395 (1995). https://doi.org/10.1007/BF00194956
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00194956